CRH Medical Corporation and WovenX Announce Strategic Partnership to Advance GI Patient Access and Streamline Care Delivery
ATLANTA & CHICAGO--(BUSINESS WIRE)--CRH Medical Corporation (' CRH '), a leading provider of products and services for gastrointestinal (GI) providers and a wholly owned subsidiary of WELL Health Technologies Corp. (' WELL '), has announced a strategic partnership with WovenX Health (' WovenX '), a leader in integrated virtual specialty care. Together, they aim to deliver integrated, next-generation GI practice solutions designed to resolve persistent challenges surrounding patient access and operational capacity.
This collaboration merges CRH's clinically validated GI solutions with WovenX's advanced virtual visit platform to create a scalable framework that enhances operational performance, expands patient access, and elevates care delivery across the GI community. WovenX's on-demand service offering enables practices to increase appointment availability, unlocks underutilized capacity in high-value procedural areas, streamline workflows, and deliver timely, patient-centered care at the speed of need.
'Partnering with WovenX Health lets GI practices deliver technology-enabled, guideline-based care in minutes rather than months,' said Russ Arjal MD, AGAF, Co-Founder and Chief Medical Officer at WovenX . 'Patients consistently praise the experience, and our Net Promoter Score ranks among the highest in healthcare. This approach enables practices to unlock new growth opportunities and capture meaningful downstream revenue. We are excited to partner with CRH to deepen our impact and expand our presence within the GI community.'
Together, WovenX and CRH are addressing long-standing barriers to access and efficiency, offering providers a cohesive and consumer-centric model for GI care.
'This partnership represents a strategic extension of the solutions we're already delivering to our GI physician customers, amplifying the value of our collaborative approach,' said Jay Kreger, CEO of CRH Medical Corporation. 'By combining CRH's GI expertise and network with WovenX's intelligent platform, we're equipping practices with the tools they need to improve patient access and outcomes, raise standards of care, and drive meaningful, long-term transformation in care delivery.'
About WELL Health Technologies Corp.
WELL's mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL's comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL's solutions enable more than 42,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 210 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol 'WELL' and on the OTC Exchange under the symbol 'WHTCF'. To learn more about WELL, please visit: www.well.company.
About CRH Medical Corporation
CRH is a North American company focused on providing gastroenterologists with innovative services and products for the treatment of gastrointestinal diseases. CRH also provides locum tenens and permanent placement anesthesia staffing solutions to provider groups, hospitals, and ASCs. In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. To date, CRH has completed 50 acquisitions, and now serves over 140 ASCs in 20 states. In addition, CRH owns the 'CRH O'Regan System,' a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. Learn more at https://crhmedcorp.com.
About WovenX Health
WovenX Health is redefining specialty care through its on-demand platform by integrating intelligent technology, GI-trained virtual care teams, and proven operational workflows into a cohesive, scalable solution. Designed to accelerate access, elevate clinical performance, and simplify patient journeys, WovenX empowers healthcare organizations to thrive, delivering Care to the Power of Now. Learn more at www.wovenxhealth.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
3 days ago
- Business Insider
RBC Capital Keeps Their Buy Rating on CRH plc (CRH)
In a report released on June 16, Anthony Codling from RBC Capital maintained a Buy rating on CRH plc (CRH – Research Report), with a price target of $108.00. The company's shares closed yesterday at p6,678.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Codling is a 4-star analyst with an average return of 10.1% and a 63.10% success rate. Codling covers the Consumer Cyclical sector, focusing on stocks such as Bellway, Vistry Group, and Crest Nicholson Holdings. The word on The Street in general, suggests a Strong Buy analyst consensus rating for CRH plc with a p8,174.08 average price target. CRH market cap is currently £45.09B and has a P/E ratio of 18.20. Based on the recent corporate insider activity of 34 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CRH in relation to earlier this year.
Yahoo
5 days ago
- Yahoo
RBC initiates Knife River, Martin Marietta amid continued infrastructure spending
-- RBC Capital Markets began coverage of Knife River Corp and Martin Marietta Material, noting difference in in margin profiles among U.S. aggregates producers as infrastructure spending continues to support the sector. The bank rated Knife River Outperform with a $129 price target on potential for earnings growth through margin improvement. Martin Marietta was initiated at Sector Perform with a $515 target, reflecting its already high margins. Vulcan Materials (NYSE:VMC) and CRH (NYSE:CRH) were rated at Sector Perform and Outperform respectively. RBC noted that while all major U.S. aggregates firms are benefiting from federally funded infrastructure programs, their positioning and profitability vary. Knife River, which was spun out from MDU Resources in 2023, is seen as earlier in its margin expansion cycle compared to more mature peers like Martin Marietta and Vulcan. The analysts said that firm-level differences in exposure to weather, regional gas tax funding, and the mix of construction materials influence operating results. The note includes a breakdown of cost structures across cement, ready mix, asphalt and gypsum segments, and maps company asset locations by U.S. state. RBC also made minor estimate changes to Cemex, CRH, Buzzi Unicem (BIT:BZU), and Vulcan. While Martin Marietta and Vulcan remain the most widely followed names in the sector, RBC said investors may be overlooking Knife River's potential for margin growth and CRH's integration advantages in North America. Heidelberg (ETR:HDDG) Materials was also cited as having underappreciated U.S. assets. Brokerage said the June 23 market debut of Amrize, a CRH spinout, could further shift investor attention toward the sector. Related articles RBC initiates Knife River, Martin Marietta amid continued infrastructure spending Deutsche Bank is now bullish on Cisco - highlights AI tailwinds Boeing Commercial Airplanes head meets Air India chairman after fatal 787 crash
Yahoo
11-06-2025
- Yahoo
Colliers publishes 2024 Global Sustainability Report
Launches refreshed sustainability strategy Built to Last TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- Colliers (NASDAQ and TSX: CIGI) released its 2024 Global Sustainability Report, highlighting the firm's achievements and progress against targets established in 2021. The report also offers a first look at Colliers' refreshed sustainability strategy, Built to Last, which is based on an updated materiality assessment conducted in the first quarter of 2025. The strategy is designed to align Colliers' priorities with today's most pressing environmental, social, and governance challenges and opportunities, anchored around three core pillars: Environmental sustainability: Supporting decarbonization and climate resilience Workplace experience: Creating inclusive, healthy, high-performing spaces Ethical governance & practices: Embedding trust, transparency, and responsible innovation 'As a global provider of real estate, engineering and investment management services, we are in a unique position to help owner, investor and occupier clients realize their sustainability aspirations while driving the same positive impact for our own operations,' said Jay Hennick, Global Chairman & CEO of Colliers. 'I'm proud of our 2024 performance and remaining agile in our approach to what's next. I look forward to continuing our journey toward a more sustainable future though Built to Last.' Highlights from the 2024 report include: Achieved a 27.6% reduction in Scope 1 and 2 emissions per square foot from our 2021 baseline. Earned WELL Health-Safety Ratings in 87.4% of Colliers offices ≥ 2,500 sq. ft., up from 35% in 2022. Expanded our electric vehicle fleet to 170+, representing a 5x increase in just two years. Reached 88% participation in our global employee engagement survey, with scores exceeding external benchmarks. 68% of our Colliers Gives volunteering goal achieved. To support the next phase of our sustainability leadership, Tonya Lagrasta has been appointed Global Head of Sustainability at Colliers. A long-time sustainability leader and trusted advisor within our business, Tonya brings more than 20 years of experience across sectors including commercial real estate, retail, consumer goods, financial services, pharmaceuticals, and the public sector. In this role she will spearhead the implementation of Built to Last and drive integration of sustainability across Colliers. 'Sustainability is a reflection of our values in action, and a pathway to long-term resilience,' said Lagrasta. 'Built to Last reflects where we are today – and more importantly, where we're going. I'm energized by our people's passion and proud to help lead this next chapter of impact.' The full 2024 Global Sustainability Report is available at About Colliers Colliers (NASDAQ, TSX: CIGI) is a global diversified professional services and investment management company. Operating through three industry-leading platforms – Real Estate Services, Engineering, and Investment Management – we have a proven business model, an enterprising culture, and a unique partnership philosophy that drives growth and value creation. For 30 years, Colliers has consistently delivered approximately 20% compound annual returns for shareholders, fueled by visionary leadership, significant inside ownership and substantial recurring earnings. With nearly $5.0 billion in annual revenues, a team of 23,000 professionals, and more than $100 billion in assets under management, Colliers remains committed to accelerating the success of our clients, investors, and people worldwide. Learn more at X @Colliers or LinkedIn. Media Contact Andrea CheungSenior Manager, Global Integrated Communications+1 416 324 in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
